[New trends in antimicrobial therapy of chronic purulent mesotympanitis].
Antibiotic therapy with colbiocin of chronic purulent mesotympanitis achieved a response rate of 92%, recurrence-free interval reached 6 months in 84% of the treated patients. This allows to recommend colbiocin as a drug of choice in hospital and outpatient treatment of chronic purulent mesotympanitis.
Tsetsarskiĭ
B M
BM
Mikhalashvili
A E
AE
Makhlinovskaia
N V
NV
Koshel'
V I
VI
Faians
A A
AA
Semenova
F S
FS
D002701:Chloramphenicol / Q000627:therapeutic use*; D002908:Chronic Disease; D003091:Colistin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D010035:Otitis Media, Suppurative / Q000188:drug therapy*; D013752:Tetracycline / Q000627:therapeutic use*
D002701:Chloramphenicol; D013752:Tetracycline; D003091:Colistin